Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project

Abstract Background Given the high prevalence of cognitive dysfunction in people with multiple sclerosis (PWMS) and the lack of availability of specialized neuropsychological services in most MS Clinics, there is a need for a brief cognitive monitoring tool that can be easily administered by MS clin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the neurological sciences 2016-03, Vol.362, p.147-152
Hauptverfasser: Walker, Lisa A.S, Osman, Leila, Berard, Jason A, Rees, Laura M, Freedman, Mark S, MacLean, Heather, Cousineau, Denis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 152
container_issue
container_start_page 147
container_title Journal of the neurological sciences
container_volume 362
creator Walker, Lisa A.S
Osman, Leila
Berard, Jason A
Rees, Laura M
Freedman, Mark S
MacLean, Heather
Cousineau, Denis
description Abstract Background Given the high prevalence of cognitive dysfunction in people with multiple sclerosis (PWMS) and the lack of availability of specialized neuropsychological services in most MS Clinics, there is a need for a brief cognitive monitoring tool that can be easily administered by MS clinic staff. Objective We aimed to establish the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) as a feasible cognitive monitoring tool and provide Canadian data toward the international validation effort. Secondary considerations were to determine if BICAMS correlates with self-reported cognition and predicted vocational status. Methods 57 PWMS were matched to 51 healthy controls (age, sex, education). Participants completed the BICAMS battery which includes the Symbol Digit Modalities Test, and the learning trials from the California Verbal Learning Test-II and the Brief Visuospatial Memory Test-Revised. Depression, self-reported cognition, and fatigue were assessed. Participants were re-tested 15.6 (SD 2.0) days later. Results With impairment defined as “one or more abnormal tests,” 57.9% of MS sample was cognitively impaired. Participants were more likely to be impaired on the BVMT-R (43.9%). On the SDMT and CVLT-II, 28.1% and 26.3% of MS participants were impaired. Sensitivity and specificity were highest for the SDMT. The BICAMS was reliable over time (r value range from 0.69 for BVMT-R to 0.87 for SDMT) with the SDMT being most robust. There was no relationship between BICAMS and subjective cognition. The BVMT-R reliably predicted employment. Conclusions The BICAMS detected cognitive impairment to a comparable degree to more comprehensive neuropsychological batteries and is a valid measure of cognition in MS. Reliability of components varies, suggesting care be taken when interpreting serial testing results. The BICAMS is a feasible cognitive assessment tool in Canadians and yields comparable results to other cultures.
doi_str_mv 10.1016/j.jns.2016.01.040
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790954189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022510X16300417</els_id><sourcerecordid>1790954189</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-f4d0bf81938b5bccec1d4ef8b5cb19dd59069768f2062ca98b9893a5e560f0463</originalsourceid><addsrcrecordid>eNqFUsuKFDEUDaI47egHuJEsx0WXN_VMFISZxsfADC5awV1IpW5pynTSk6Qa5gv8bVP2KOhCV8mF80jOuYQ8ZVAwYO2LqZhcLMp8LYAVUMM9smK84-uG8-o-WQGU5bph8PmEPIpxAoCWc_GQnJStqGtWdSvy_SIYHOmlSxicSsY7ZenGf3EmmQPS8xgxxh26REcf6PVsk9lbpFttMfhoIj27uNycX2-fv6Qb5dRglKPauxRMPy9qNHmaviI1fxgclDXDz4Hug59Qp8fkwahsxCd35yn59PbNx8379dWHd9ngaq3zg9N6rAfoR85Exfum1xo1G2oc86B7JoahEdCKruVjCW2pleC94KJSDTYtjFC31Sk5O-pm35sZY5I7EzVaqxz6OUrWCRBNzTLr_9AOctglbzKUHaE6hxIDjnIfzE6FW8lALlXJSeaq5FKVBCZzVZnz7E5-7nc4_Gb86iYDXh0BmPM4GAwyaoNO42BCTkwO3vxT_vVfbG2NM1rZb3iLcfJzrsPmX8hYSpDbZVeWVWFtBVCzrvoByXO7Ag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770878285</pqid></control><display><type>article</type><title>Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Walker, Lisa A.S ; Osman, Leila ; Berard, Jason A ; Rees, Laura M ; Freedman, Mark S ; MacLean, Heather ; Cousineau, Denis</creator><creatorcontrib>Walker, Lisa A.S ; Osman, Leila ; Berard, Jason A ; Rees, Laura M ; Freedman, Mark S ; MacLean, Heather ; Cousineau, Denis</creatorcontrib><description>Abstract Background Given the high prevalence of cognitive dysfunction in people with multiple sclerosis (PWMS) and the lack of availability of specialized neuropsychological services in most MS Clinics, there is a need for a brief cognitive monitoring tool that can be easily administered by MS clinic staff. Objective We aimed to establish the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) as a feasible cognitive monitoring tool and provide Canadian data toward the international validation effort. Secondary considerations were to determine if BICAMS correlates with self-reported cognition and predicted vocational status. Methods 57 PWMS were matched to 51 healthy controls (age, sex, education). Participants completed the BICAMS battery which includes the Symbol Digit Modalities Test, and the learning trials from the California Verbal Learning Test-II and the Brief Visuospatial Memory Test-Revised. Depression, self-reported cognition, and fatigue were assessed. Participants were re-tested 15.6 (SD 2.0) days later. Results With impairment defined as “one or more abnormal tests,” 57.9% of MS sample was cognitively impaired. Participants were more likely to be impaired on the BVMT-R (43.9%). On the SDMT and CVLT-II, 28.1% and 26.3% of MS participants were impaired. Sensitivity and specificity were highest for the SDMT. The BICAMS was reliable over time (r value range from 0.69 for BVMT-R to 0.87 for SDMT) with the SDMT being most robust. There was no relationship between BICAMS and subjective cognition. The BVMT-R reliably predicted employment. Conclusions The BICAMS detected cognitive impairment to a comparable degree to more comprehensive neuropsychological batteries and is a valid measure of cognition in MS. Reliability of components varies, suggesting care be taken when interpreting serial testing results. The BICAMS is a feasible cognitive assessment tool in Canadians and yields comparable results to other cultures.</description><identifier>ISSN: 0022-510X</identifier><identifier>EISSN: 1878-5883</identifier><identifier>DOI: 10.1016/j.jns.2016.01.040</identifier><identifier>PMID: 26944137</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Analysis of Variance ; BICAMS ; Canada ; Cognition ; Cognition Disorders - diagnosis ; Cognition Disorders - etiology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multiple sclerosis ; Multiple Sclerosis - complications ; Neurology ; Neuropsychological Tests - standards ; Neuropsychology ; Reliability ; Reproducibility of Results ; ROC Curve ; Validity</subject><ispartof>Journal of the neurological sciences, 2016-03, Vol.362, p.147-152</ispartof><rights>Elsevier B.V.</rights><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-f4d0bf81938b5bccec1d4ef8b5cb19dd59069768f2062ca98b9893a5e560f0463</citedby><cites>FETCH-LOGICAL-c441t-f4d0bf81938b5bccec1d4ef8b5cb19dd59069768f2062ca98b9893a5e560f0463</cites><orcidid>0000-0001-5865-7257</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jns.2016.01.040$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,46002</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26944137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walker, Lisa A.S</creatorcontrib><creatorcontrib>Osman, Leila</creatorcontrib><creatorcontrib>Berard, Jason A</creatorcontrib><creatorcontrib>Rees, Laura M</creatorcontrib><creatorcontrib>Freedman, Mark S</creatorcontrib><creatorcontrib>MacLean, Heather</creatorcontrib><creatorcontrib>Cousineau, Denis</creatorcontrib><title>Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description>Abstract Background Given the high prevalence of cognitive dysfunction in people with multiple sclerosis (PWMS) and the lack of availability of specialized neuropsychological services in most MS Clinics, there is a need for a brief cognitive monitoring tool that can be easily administered by MS clinic staff. Objective We aimed to establish the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) as a feasible cognitive monitoring tool and provide Canadian data toward the international validation effort. Secondary considerations were to determine if BICAMS correlates with self-reported cognition and predicted vocational status. Methods 57 PWMS were matched to 51 healthy controls (age, sex, education). Participants completed the BICAMS battery which includes the Symbol Digit Modalities Test, and the learning trials from the California Verbal Learning Test-II and the Brief Visuospatial Memory Test-Revised. Depression, self-reported cognition, and fatigue were assessed. Participants were re-tested 15.6 (SD 2.0) days later. Results With impairment defined as “one or more abnormal tests,” 57.9% of MS sample was cognitively impaired. Participants were more likely to be impaired on the BVMT-R (43.9%). On the SDMT and CVLT-II, 28.1% and 26.3% of MS participants were impaired. Sensitivity and specificity were highest for the SDMT. The BICAMS was reliable over time (r value range from 0.69 for BVMT-R to 0.87 for SDMT) with the SDMT being most robust. There was no relationship between BICAMS and subjective cognition. The BVMT-R reliably predicted employment. Conclusions The BICAMS detected cognitive impairment to a comparable degree to more comprehensive neuropsychological batteries and is a valid measure of cognition in MS. Reliability of components varies, suggesting care be taken when interpreting serial testing results. The BICAMS is a feasible cognitive assessment tool in Canadians and yields comparable results to other cultures.</description><subject>Adult</subject><subject>Analysis of Variance</subject><subject>BICAMS</subject><subject>Canada</subject><subject>Cognition</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - etiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - complications</subject><subject>Neurology</subject><subject>Neuropsychological Tests - standards</subject><subject>Neuropsychology</subject><subject>Reliability</subject><subject>Reproducibility of Results</subject><subject>ROC Curve</subject><subject>Validity</subject><issn>0022-510X</issn><issn>1878-5883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUsuKFDEUDaI47egHuJEsx0WXN_VMFISZxsfADC5awV1IpW5pynTSk6Qa5gv8bVP2KOhCV8mF80jOuYQ8ZVAwYO2LqZhcLMp8LYAVUMM9smK84-uG8-o-WQGU5bph8PmEPIpxAoCWc_GQnJStqGtWdSvy_SIYHOmlSxicSsY7ZenGf3EmmQPS8xgxxh26REcf6PVsk9lbpFttMfhoIj27uNycX2-fv6Qb5dRglKPauxRMPy9qNHmaviI1fxgclDXDz4Hug59Qp8fkwahsxCd35yn59PbNx8379dWHd9ngaq3zg9N6rAfoR85Exfum1xo1G2oc86B7JoahEdCKruVjCW2pleC94KJSDTYtjFC31Sk5O-pm35sZY5I7EzVaqxz6OUrWCRBNzTLr_9AOctglbzKUHaE6hxIDjnIfzE6FW8lALlXJSeaq5FKVBCZzVZnz7E5-7nc4_Gb86iYDXh0BmPM4GAwyaoNO42BCTkwO3vxT_vVfbG2NM1rZb3iLcfJzrsPmX8hYSpDbZVeWVWFtBVCzrvoByXO7Ag</recordid><startdate>20160315</startdate><enddate>20160315</enddate><creator>Walker, Lisa A.S</creator><creator>Osman, Leila</creator><creator>Berard, Jason A</creator><creator>Rees, Laura M</creator><creator>Freedman, Mark S</creator><creator>MacLean, Heather</creator><creator>Cousineau, Denis</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><orcidid>https://orcid.org/0000-0001-5865-7257</orcidid></search><sort><creationdate>20160315</creationdate><title>Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project</title><author>Walker, Lisa A.S ; Osman, Leila ; Berard, Jason A ; Rees, Laura M ; Freedman, Mark S ; MacLean, Heather ; Cousineau, Denis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-f4d0bf81938b5bccec1d4ef8b5cb19dd59069768f2062ca98b9893a5e560f0463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Analysis of Variance</topic><topic>BICAMS</topic><topic>Canada</topic><topic>Cognition</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - etiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - complications</topic><topic>Neurology</topic><topic>Neuropsychological Tests - standards</topic><topic>Neuropsychology</topic><topic>Reliability</topic><topic>Reproducibility of Results</topic><topic>ROC Curve</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walker, Lisa A.S</creatorcontrib><creatorcontrib>Osman, Leila</creatorcontrib><creatorcontrib>Berard, Jason A</creatorcontrib><creatorcontrib>Rees, Laura M</creatorcontrib><creatorcontrib>Freedman, Mark S</creatorcontrib><creatorcontrib>MacLean, Heather</creatorcontrib><creatorcontrib>Cousineau, Denis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walker, Lisa A.S</au><au>Osman, Leila</au><au>Berard, Jason A</au><au>Rees, Laura M</au><au>Freedman, Mark S</au><au>MacLean, Heather</au><au>Cousineau, Denis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>2016-03-15</date><risdate>2016</risdate><volume>362</volume><spage>147</spage><epage>152</epage><pages>147-152</pages><issn>0022-510X</issn><eissn>1878-5883</eissn><abstract>Abstract Background Given the high prevalence of cognitive dysfunction in people with multiple sclerosis (PWMS) and the lack of availability of specialized neuropsychological services in most MS Clinics, there is a need for a brief cognitive monitoring tool that can be easily administered by MS clinic staff. Objective We aimed to establish the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) as a feasible cognitive monitoring tool and provide Canadian data toward the international validation effort. Secondary considerations were to determine if BICAMS correlates with self-reported cognition and predicted vocational status. Methods 57 PWMS were matched to 51 healthy controls (age, sex, education). Participants completed the BICAMS battery which includes the Symbol Digit Modalities Test, and the learning trials from the California Verbal Learning Test-II and the Brief Visuospatial Memory Test-Revised. Depression, self-reported cognition, and fatigue were assessed. Participants were re-tested 15.6 (SD 2.0) days later. Results With impairment defined as “one or more abnormal tests,” 57.9% of MS sample was cognitively impaired. Participants were more likely to be impaired on the BVMT-R (43.9%). On the SDMT and CVLT-II, 28.1% and 26.3% of MS participants were impaired. Sensitivity and specificity were highest for the SDMT. The BICAMS was reliable over time (r value range from 0.69 for BVMT-R to 0.87 for SDMT) with the SDMT being most robust. There was no relationship between BICAMS and subjective cognition. The BVMT-R reliably predicted employment. Conclusions The BICAMS detected cognitive impairment to a comparable degree to more comprehensive neuropsychological batteries and is a valid measure of cognition in MS. Reliability of components varies, suggesting care be taken when interpreting serial testing results. The BICAMS is a feasible cognitive assessment tool in Canadians and yields comparable results to other cultures.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26944137</pmid><doi>10.1016/j.jns.2016.01.040</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-5865-7257</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-510X
ispartof Journal of the neurological sciences, 2016-03, Vol.362, p.147-152
issn 0022-510X
1878-5883
language eng
recordid cdi_proquest_miscellaneous_1790954189
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Analysis of Variance
BICAMS
Canada
Cognition
Cognition Disorders - diagnosis
Cognition Disorders - etiology
Female
Follow-Up Studies
Humans
Male
Middle Aged
Multiple sclerosis
Multiple Sclerosis - complications
Neurology
Neuropsychological Tests - standards
Neuropsychology
Reliability
Reproducibility of Results
ROC Curve
Validity
title Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T10%3A26%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Brief%20International%20Cognitive%20Assessment%20for%20Multiple%20Sclerosis%20(BICAMS):%20Canadian%20contribution%20to%20the%20international%20validation%20project&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Walker,%20Lisa%20A.S&rft.date=2016-03-15&rft.volume=362&rft.spage=147&rft.epage=152&rft.pages=147-152&rft.issn=0022-510X&rft.eissn=1878-5883&rft_id=info:doi/10.1016/j.jns.2016.01.040&rft_dat=%3Cproquest_cross%3E1790954189%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1770878285&rft_id=info:pmid/26944137&rft_els_id=S0022510X16300417&rfr_iscdi=true